Press Releases
News
Careers
Contact

Home
About
Leadership
Pipeline
Technology
Investors
Patients
News
Careers
Contact

Recent Posts

BiotechTV: Checking in with Artiva CEO Fred Aslan after the Company’s $167 Million IPO
Pharmaphorum Podcast: Move over CAR-T – the Potential of NK Cells in Cell Therapy
Cell & Gene: NK Cell Therapies – How Artiva Biotherapeutics Leverages Its “Manufacturing First” Approach
BiotechTV: Using NK Cell Therapies for Autoimmune Disease and Cancer with Artiva’s CEO
Clinical Trials Arena: Artiva Prepares to Kick off Phase I/II Trial for NK Cell Therapy

Archives

August 2024
May 2024
April 2024
March 2024
February 2024
December 2023
November 2023

Categories

Artiva In the News

Archives

August 2024
May 2024
April 2024
March 2024
February 2024
December 2023
November 2023

Category: Executives

Fred Aslan, M.D.

Jennifer Bush

Thorsten Graef, M.D., Ph.D.

Christopher Horan

Neha Krishnamohan

Eugene Helsel

John Lim, Pharm.D.

Heather Raymon, Ph.D.

Nicholas Veomett, Ph.D.

Contact

Privacy Policy
Terms

© Artiva Biotherapeutics, Inc., 2024

Sign up for news updates

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.AcceptPrivacy Policy